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Abstract
Background: Myocardial bridging is present when a segment of a major epicardial coronary artery runs
intramurally through the myocardium. It usually has a benign prognosis, but in some cases myocardial ischemia,
infarction and sudden cardiac death have been reported. We are here reporting a case of myocardial bridging
which was complicated with recurrent chest pain and transient ST-segment elevation during exercise treadmill test.
Case presentation: A 40 year-old-man presented with recurrent retrosternal chest pain of 2 months duration. He
had history of smoking and was obese, otherwise no physical abnormalities were detected by examination.
Electrocardiogram and blood tests were normal apart from impaired glucose tolerance with elevated triglycerides
and decreased level of high density lipoprotein cholesterol. While doing exercise treadmill test, the patient
developed chest pain and significant ST-segment elevation in almost all precordial leads that persisted for about
15 minutes through recovery. We decided to admit the patient to the coronary care unit for further management
and to perform coronary angiogram. Myocardial bridging was observed in the mid segment of the left anterior
descending coronary artery. Medical treatment was decided.
At one year follow up, our patient was healthy and had no cardiac complaints. In conclusion, myocardial bridging
may predispose to coronary vasospasm that may leads to ischemic complications.
Background
The major coronary arteries are located in the sub-epi-
cardial region [1]. Localization of a major coronary
arterial segment, the ‘tunnelled artery’, in the myocardial
tissue is termed myocardial bridging; a congenital cor-
onary anomaly [2]. In these patients, there is a tempor-
ary systolic coronary arterial luminal narrowing.
Symptomatic patients are most often middle-aged men
with typical or atypical chest pain, either related or
unrelated to exercise [1,3]. Myocardial bridging usually
has a benign prognosis, but some cases associated with
myocardial ischemia [4], infarction [5], coronary spasm
[6], arrhythmias [7], and sudden death [8] have been
reported.
Case presentation
A 40 year-old-man was evaluated at our out patient
clinic complaining of recurrent compressing retrosternal
chest pain of 2 months duration. That pain occurred at
rest or with exertion and sometimes awake the patient
from sleep. He had history of smoking but no history of
diabetes, hypertension, dyslipidemia, and no family his-
tory of coronary artery disease. His body mass index
was 37 kg/m
2 and waist circumference 115 cm.
No physical abnormalities were detected by clinical
examination and blood pressure was 130/85 mmHg.
Resting ECG was normal and blood tests revealed tri-
glycerides 1.8 mmol/L, high density lipoprotein choles-
terol 0.57 mmol/L, total cholesterol 4.15 mmol/L, low
density lipoprotein cholesterol 2.77 mmol/L, fasting
blood glucose 6.8 mmol/L, post prandial glucose 9.9
mmol/L, glycosylated hemoglobin (HbA1c) 7.0%. All
other blood tests were normal.
We decided to perform exercise stress test using
CAEP protocol (The Chronotropic Assessment Exercise
Protocol). Blood pressure, heart rate and 12-leads ECG
were recorded at rest, at two-minute intervals during
exercise, at peak exercise, and through the recovery
phase. The ECG and ST-segment were continuously dis-
played and measured automatically by a computer-
assisted system in all 12 leads. At heart rate of 144 beat/
minute, the ST segment showed progressive elevation Correspondence: mhmdabdou232@yahoo.com
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any medium, provided the original work is properly cited.and the patient reported chest pain that necessitated ter-
mination of the test. The patient received oxygen and
sublingual nitroglycerin and was reassured until disap-
pearance of chest pain accompanied with complete
recovery of ST-segment after about 15 minutes from
cessation of exercise (Figures 1, 2, 3, 4).
The patient was transferred to the CCU for observa-
tion and medical treatment. He was given oral acetylsa-
licylic acid, 300 mg per day; clopidogril 300 mg 1
st
day,75 mg thereafter; enoxaparin, 1 mg/kg/12 h; meto-
prolol, 50 mg per day;atorvastatin 20 mg per day. Serial
cardiac enzymes values were normal.
Two days later, coronary angiography and left ventri-
culography were performed. The left coronary system
was imaged at left and right oblique, right cranial and
caudal and anteroposterior cranial positions. Significant
coronary artery systolic luminal narrowing was observed
in the mid segment of the left anterior descending cor-
onary artery at left anterior oblique cranial position on
coronary angiogram (Figure 5). The right coronary
artery was normal and ventriculogram revealed pre-
served systolic function without wall motion abnormal-
ities, or mitral regurge.
The patient was discharged on metoprolol 50 mg per
day, oral acetylsalicylic acid, 81 mg per day, and atorvas-
tatin 20 mg per day with complete instructions for risk
factors modification.
At the one year follow up, our patient was healthy and
had no cardiac complaints.
Discussion
Myocardial bridging can be seen as an incidental finding
at coronary arteriography. Previous studies have
reported its prevalence at 1.5 to 16% when assessed by
coronary angiography but in some autopsy series, it is as
high as 80% [9,10]. Left anterior descending coronary
artery was exclusively involved by 70% [11]. Because
myocardial bridging is a common finding at autopsy of
normal subjects, it had been thought to be a benign
anatomic variation [12]. In spite that myocardial brid-
ging rarely causes myocardial ischemia [11], previous
reports have demonstrated its pathologic potential.
Stable or unstable angina pectoris [4,13], acute myocar-
dial infarction [5,14], complete atrioventricular block
[7,15] or sudden death [8] associated with myocardial
bridges have been described.
Figure 1 Early phase of exercise treadmill test with normal tracing.
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Page 2 of 6Figure 2 Maximal exercise at which the test was terminated with ST-segment elevation in precordial leads.
Figure 3 Recovery phase of exercise treadmill test with still elevated ST-segment in precordial leads.
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Figure 5 Systolic compression at the mid-portion of LAD at the LAO view (A), with normalization of systolic compression (B).
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coronary syndrome consists of atherosclerotic plaque
disruption and thrombus formation [16].
This was the provisional diagnosis in our patient as he
was smoking and had criteria of cardiac metabolic syn-
drome. The second possibility was coronary spasm on
atherosclerotic plaque. So, we recommended the CCU
management for our patient. There is evidence that the
arterial segment proximal to the myocardial bridge has
a higher frequency of atherosclerosis, whereas the tun-
nelled segment is relatively spared despite evidence of
endothelial dysfunction, which could predispose to cor-
onary vasospasm and thrombosis [17,18].
The degree of coronary obstruction by the myocardial
bridge depends on such factors as location superficial’
or’deep’, thickness, length of the muscle bridge, and
degree of cardiac contractility [12]. Possible explanation
of changes occurred during exercise in our patient could
be severe coronary spasm depending on multiple of these
factors. Vessel compression within the myocardial bridge
is not solely a systolic event but persists throughout a
large portion of diastole as evidenced with intravascular
ultrasonography [19]. Although this malformation is pre-
sent at birth, symptoms usually do not develop before the
third decade, like the case in our report; the reason for
this is not clear [12]. Coronary angiography was planned.
However, no atheroscleroticp l a q u ei nt h em a j o rc o r o n -
ary arteries was detected. There was temporary systolic
coronary arterial luminal narrowing at the mid-portion
of the left anterior descending coronary artery at left
anterior oblique view. Therefore, we decided to follow
the patient conservatively. At one year follow-up and
without doing stress test, we obtained an excellent result
at least in symptom relieve with risk factors modification,
B-blokers, statins, and oral acetylsalicylic acid. Nitrates
generally was avoided because they increase the angio-
graphic degree of systolic narrowing and can lead to wor-
sening of the symptoms [20]. On the other hand, ß-
blockers decrease the tachycardia and increase diastolic
time, with a decrease in contractility and compression of
the coronary arteries. This was evidenced with intrave-
nous injection of esmolol during tachypacing in sympto-
matic patients with severe myocardial bridging showing
decrease Doppler flow velocities, with a return to baseline
values and normalization of the diastolic-to-systolic flow
velocity ratio within the bridged segment [21]. In spite
that acetylsalicylic acid can worse coronary spasm, most
in coronary arteries without atherosclerosis, even at low
doses [22]. However, endothelial damage, platelet aggre-
gation and thrombus formation may occur at the site of
focal arterial constriction even when the reduction in
transluminal diameter is insufficient to alter substantially
the rate of flow [23] and hence acetylsalicylic acid can be
useful specially in our patient with cardiac metabolic
syndrome. Intracoronary stents, coronary artery bypass
graft, and surgical myotomy may be the final way to treat
but which patient should be selected for invasive or sur-
gical therapy is still a matter of debate.
Conclusion
Myocardial bridging may predispose to coronary vasos-
pasm that may leads to ischemic complications. This
report, together with those previously published, sug-
gests that myocardial bridging may no longer be consid-
ered simply a benign variation of coronary anatomy.
Inotropic challenge possibly should be considered for
assessing the clinical importance of certain myocardial
bridges. However, objective signs of ischemia cannot
always be demonstrated in patients with myocardial
bridging, most likely because of a large variability.
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